scholarly article | Q13442814 |
P50 | author | Joshua Yang | Q58136758 |
Sindhu Chandran | Q88445343 | ||
P2093 | author name string | J A Bluestone | |
Q Tang | |||
M Fitch | |||
K Lee | |||
J Leung | |||
T Sigdel | |||
V Nguyen | |||
F Vincenti | |||
M Hellerstein | |||
M Sarwal | |||
Z G Laszik | |||
E C Tavares | |||
A L Putnam | |||
P2860 | cites work | Regulatory T-cell therapy in transplantation: moving to the clinic | Q27025869 |
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation | Q34162461 | ||
Fibrosis with inflammation at one year predicts transplant functional decline. | Q34457101 | ||
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer | Q34536661 | ||
Messenger RNA for FOXP3 in the urine of renal-allograft recipients | Q34563002 | ||
Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region. | Q35252405 | ||
Central Role of CD45RA- Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation Tolerance | Q35903107 | ||
Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties | Q36104784 | ||
Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation | Q36281955 | ||
Type 1 diabetes immunotherapy using polyclonal regulatory T cells | Q36509805 | ||
CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects | Q36826059 | ||
A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance | Q36888933 | ||
Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. | Q36906015 | ||
The Foxp3+ regulatory T cell: a jack of all trades, master of regulation | Q37088900 | ||
Expansion of human regulatory T-cells from patients with type 1 diabetes | Q37105331 | ||
Regulatory T cells in kidney disease and transplantation | Q38855295 | ||
Isolation, expansion and functional assessment of CD4+CD25+FoxP3+ regulatory T cells and Tr1 cells from uremic patients awaiting kidney transplantation | Q39702510 | ||
Ex Vivo Costimulatory Blockade to Generate Regulatory T Cells From Patients Awaiting Kidney Transplantation. | Q40083199 | ||
Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis | Q44688981 | ||
Natural history, risk factors, and impact of subclinical rejection in kidney transplantation | Q44997881 | ||
Identifying specific causes of kidney allograft loss. | Q45810388 | ||
Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipients | Q50073303 | ||
A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation. | Q52888768 | ||
The Banff 97 working classification of renal allograft pathology | Q59314413 | ||
Subclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft Loss | Q62619830 | ||
Functionally significant renal allograft rejection is defined by transcriptional criteria | Q81395033 | ||
Regulatory T cells in kidney allograft infiltrates correlate with initial inflammation and graft function | Q82632541 | ||
Long-term impact of subclinical inflammation diagnosed by protocol biopsy one year after renal transplantation | Q84870290 | ||
Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up | Q87620046 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammation | Q101991 |
P304 | page(s) | 2945-2954 | |
P577 | publication date | 2017-08-14 | |
P1433 | published in | American Journal of Transplantation | Q4744273 |
P1476 | title | Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants | |
P478 | volume | 17 |
Q54216691 | A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants. |
Q88663316 | Contemporary Strategies and Barriers to Transplantation Tolerance |
Q104264527 | Cross talk between human regulatory T cells and antigen presenting cells: Lessons for clinical applications |
Q49829282 | Current Status of Gene Engineering Cell Therapeutics |
Q100316586 | Functional CRISPR dissection of gene networks controlling human regulatory T cell identity |
Q90529882 | Generation and functional assessment of nonhuman primate regulatory dendritic cells and their therapeutic efficacy in renal transplantation |
Q47138817 | Good Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders |
Q52732932 | HLA variation and disease. |
Q58105822 | High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population |
Q95645095 | Kidney transplantation: a safe step forward for regulatory immune cell therapy |
Q49403463 | Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization |
Q90197782 | Next-generation regulatory T cell therapy |
Q64236635 | Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity |
Q97519150 | Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies |
Q88777827 | Regulatory T Cells and Kidney Transplantation |
Q50319201 | Regulatory T cells in renal disease. |
Q89910768 | Regulatory T cells in solid organ transplantation |
Q95645109 | Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials |
Q93004973 | Semaphorin 4A Stabilizes Human Regulatory T Cell Phenotype via Plexin B1 |
Q98465729 | The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology |
Q57816711 | Tolerance Induction in Relation to the Eye |
Q61805676 | Transient increase of activated regulatory T cells early after kidney transplantation |
Q50321579 | Vitamin C Fosters the In Vivo Differentiation of Peripheral CD4+ Foxp3- T Cells into CD4+ Foxp3+ Regulatory T Cells but Impairs Their Ability to Prolong Skin Allograft Survival. |
Q64110642 | Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective |
Search more.